Patterns of acute poisoning with pesticides in the paediatric age group

Kavinda Chandimal Dayasiri1, Shaluka F Jayamanne2, Chamilka Y Jayasinghe2

  • 1University Paediatrics Unit, Lady Ridgeway Hospital for Children, Colombo, Sri Lanka. kavindadayasiri@gmail.com.

Insights

Acute pesticide poisoning in children under 12 in rural Sri Lanka is uncommon but serious. Organophosphate and carbamate exposure caused significant morbidity, with harmful first aid and delayed care worsening outcomes.

Area of Science:

  • Pediatric Toxicology
  • Environmental Health
  • Rural Health

Background:

  • Pesticides pose global poisoning risks to children, causing significant morbidity.
  • Pesticide self-poisoning is common in rural adult populations in Sri Lanka.
  • Limited data exists on acute pesticide poisoning in children in rural Sri Lanka.

Purpose of the Study:

  • To comprehensively evaluate clinical profiles of acute pesticide poisoning in children.
  • To assess harmful first aid practices and emergency management.
  • To determine complications and outcomes in pediatric pesticide poisoning.

Main Methods:

  • Multicenter study in Sri Lanka's North Central Province (2007-2014).
  • Inclusion of children aged 9 months to 12 years with acute pesticide poisoning.
  • Data collection via interviewer-administered questionnaires from 36 hospitals.

Main Results:

  • 155 children (9.5%) experienced acute pesticide poisoning; most were under 5 years old.
  • Organophosphates and carbamates were the primary agents; gastrointestinal and neurological symptoms predominated.
  • Delayed management due to transport issues and caregiver concerns, with a 1.9% case fatality rate.

Conclusions:

  • Acute pesticide poisoning is a significant, though relatively uncommon, cause of pediatric morbidity and mortality in rural Sri Lanka.
  • Poisoning patterns reflect local pesticide usage.
  • Harmful first aid and delayed emergency care negatively impact patient outcomes.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
39
Types of Toxins01:36

Types of Toxins

Humans continually engage with an environment rich in potentially harmful chemicals. These are introduced to our bodies through inhalation, ingestion, or skin contact. These chemicals exist in various forms, such as air and environmental pollutants, agricultural chemicals, organic solvents, and heavy metals.
Air pollutants, primarily gases, pose significant threats to respiratory health, leading to conditions like hypoxia, lung cancer, and in extreme cases, death.
Environmental pollutants like...
3.9K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.8K
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
289
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
76
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
377